Volume 40 Supplement 2

Proceedings of the XX National Congress of the Italian Society of Neonatology

Open Access

Developmental haemostasis in moderate and late preterm infants

Italian Journal of Pediatrics201440(Suppl 2):A38

DOI: 10.1186/1824-7288-40-S2-A38

Published: 9 October 2014

Introduction

The term “developmental haemostasis” was first coined by Maureen Andrews to describe the age-related physiological changes of the coagulation system during childhood.[1] Given the age-dependent specificity of haemostasis, the evaluation and the interpretation of coagulation assays in newborns may present diagnostic difficulties and appropriate reference ranges for the diagnosis and management of coagulopathies in moderate and late preterm infants are needed.

Age-related changes in the coagulation plasma proteins

The haemostatic system is a dynamic evolving process that is age-dependent. At birth, plasma concentrations of vitamin K-dependent and contact factors (F) are decreased if compared with adult levels.[2] During the first 6 months of life, they gradually increase to values approaching adult levels.[2] These changes in protein levels lead to corresponding changes in global tests of coagulation such as the Prothrombine Time and the Activated Partial Thromboplastin Time. Plasma concentrations of fibrinogen, FV, FVIII, FXIII and von Willebrand are not decreased at birth.[2] In addition, plasma concentrations of antithrombin, protein C and protein S are low at birth, and they reach adult levels at about 6-12 months of life.[2] In the fibrinolytic system, plasma concentrations of plasminogen are decreased at birth, whereas tissue plasminogen activator and plasminogen activator inhibitor are increased.[2] These postnatal changes in the coagulation system, observed both in term and preterm neonates, are functionally balanced, suggesting a normal haemostasis during early infancy in healthy conditions.

Reference ranges of coagulation tests in moderate and late preterm infants

Considering the developmental changes of coagulation proteins in term and preterm neonates, specific age-related reference ranges are necessary for an accurate diagnosis and management of neonatal coagulation disorders. In table 1 reference ranges for coagulation assays obtained in moderate and late preterm neonates are summarized.[3] Since coagulation assays are analyzer and reagent dependent, laboratories should develop specific reference ranges to their own testing systems.[4]
Table 1

Reference values for coagulation tests in healthy moderate and late preterm neonates (30 to 36 weeks of gestation) during the first 6 months of life.

Postnatal Age

PT (s)

APTT (s)

Fibrinogen (g/L)

AT-III (U/mL)

Protein C (U/mL)

Protein S (U/mL)

Day 1

13.0

(10.6-16.2)

53.6

(27.5-79.4)

2.43

(1.50-3.73)

0.38

(0.14-0.62)

0.28

(0.12-0.44)

0.26

(0.14-0.38)

Day 5

12.5

(10.0-15.3)

50.5

(29.6-74.1)

2.80

(1.60-4.18)

0.56

(0.30-0.82)

0.31

(0.11-0.51)

0.37

(0.13-0.61)

Day 30

11.8

(10.0-13.6)

44.7

(26.9-62.5)

2.54

(1.50-4.14)

0.59

(0.37-0.81)

0.37

(0.15-0.59)

0.56

(0.22-0.90)

Day 90

12.3

(10.0-14.6)

39.5

(28.3-50.7)

2.46

(1.50-3.52)

0.83

(0.45-1.21)

0.45

(0.23-0.67)

0.76

(0.40-1.12)

Day 180

12.5

(10.0-15.0)

37.5

(21.7-53.3)

2.28

(1.50-3.60)

0.90

(0.52-1.28)

0.57

(0.31-0.83)

0.82

(0.44-1.20)

All values are given as a mean followed by lower and upper limit (95% of confidence interval). From Andrew M at al., modified.[3]

New diagnostic assays

Thromboelastography and the measurement of thrombin generation are methods that provide a global assessment of hemostasis. Recently, the use of these assays has been reported in neonates and the results suggest that these methods may offer advantages for the evaluation of developmental hemostasis. Thromboelastography, in particular, may be less sensitive to age-related changes of coagulation protein.[5, 6] However, the introduction of these methods into clinical practice of neonatal medicine should be based on larger studies confirming the predictive value of the assays.

Authors’ Affiliations

(1)
Neonatology and Neonatal Intensive Care Unit, Children’s Hospital of Brescia

References

  1. Andrew M: The relevance of developmental hemostasis to hemorrhagic disorders of newborns. Semin Perinatol. 1997, 21: 70-85. 10.1016/S0146-0005(97)80022-5.View ArticlePubMedGoogle Scholar
  2. Monagle P, Massicotte P: Developmental haemostasis: secondary haemostasis. Semin Fetal Neonatal Med. 2011, 16: 294-300. 10.1016/j.siny.2011.07.007.View ArticlePubMedGoogle Scholar
  3. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Castle V, Powers P: Development of the human coagulation system in the healthy premature infant. Blood. 1988, 72: 1651-7.PubMedGoogle Scholar
  4. Monagle P, Ignjatovic V, Savoia H: Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev. 2010, 24: 63-8. 10.1016/j.blre.2009.12.001.View ArticlePubMedGoogle Scholar
  5. Edwards RM, Naik-Mathuria BJ, Gay AN, Olutoye OO, Teruya J: Parameters of thromboelastography in healthy newborns. Am J Clin Pathol. 2008, 130: 99-102. 10.1309/LABNMY41RUD099J2.View ArticlePubMedGoogle Scholar
  6. Tripodi A, Ramenghi LA, Chantarangkul V, De Carli A, Clerici M, Groppo M, Mosca F, Mannucci PM: Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests. Haematologica. 2008, 93: 1256-9. 10.3324/haematol.12566.View ArticlePubMedGoogle Scholar

Copyright

© Motta and Russo; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.